Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/01/21
End: 05/31/24
Due: 05/31/25
Phase: N/A
Priority: Normal
Start: 11/01/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/01/23
End: 06/30/24
Due: 06/30/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis | NCT06146972 | Yanfeng Hou | user2@example.com | None | 2021-06-01 | 2024-05-31 | 2025-05-31 | - | - | 2025-07-14 |
| Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus | NCT06137053 | Yanfeng Hou | user2@example.com | None | 2022-11-01 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| Study on Lymphocyte Subsets of Peripheral Blood in Patients With Nonmyopathic Dermatomyositis Complicated With Pulmonary Interstitial Disease | NCT06149039 | Yanfeng Hou | user2@example.com | None | 2023-04-01 | 2024-06-30 | 2025-06-30 | - | - | 2025-07-14 |